A T1799A transversion resulting in valine-to-glutamate substitution at codon 600 (V600E) accounts for over 80% of all BRAF mutations [6,7], and almost all mutations in thyroid tumors [8]. The gene discussed is BRAF; the disease is thyroid tumor.